Financial Performances - 프로스테믹스
 
 

Balance Sheet - Settlement

Finance Label 2016 2015 2014
Price Composition Increase Price Composition Increase Price Composition Increase
total current assets 29,069 61.8% 0.9% 29,322 68.2% 279.5% 21,983 99.8% 0%
total non-current assets 17,948 38.2% 31.5% 13,648 31.8% 110.9% 34 .2% 0%
total assets 47,017 100% 9.4% 42,969 100% 202.7% 22,017 100% 0%
total current liabilities 1,808 3.8% 41.6% 1,277 3% 85.2% 3 0% 0%
total non-current liabilities 219 .5% 91% 2,421 5.6% 11.8% 1,623 7.4% 0%
total liabilities 2,027 4.3% 45.2% 3,699 8.6% 7.7% 1,626 7.4% 0%
capital stocks 4,517 9.6% 4.1% 4,339 10.1% 21.1% 1,052 4.8% 0%
capital surplus 32,971 70.1% 20.1% 41,246 96% 916.2% 19,304 87.7% 0%
retained earnings 4,461 9.5% 145.9% -9,716 -22.6% 680.1% 35 .2% 0%
total stockholders' equity 44,990 95.7% 14.6% 39,271 91.4% 264.9% 20,391 92.6% 0%

Income Statement - Settlement

Finance Label 2016 2015 2014
Price Composition Increase Price Composition Increase Price Composition Increase
sales(net) 14,283 100% 2.1% 14,597 100% 45.7% 0 0% 0%
gross profit 10,965 76.8% 8% 11,924 81.7% 85.2% 0 0% 0%
operating income 4,375 30.6% 29.6% 6,213 42.6% 80.3% -62 0% 0%
non-operating income 1,241 8.7% 145.8% 505 3.5% 415.6% 148 0% 0%
non-operating expenses 572 4% 96% 14,256 97.7% 4389.7% 25 0% 0%
net income 4,507 31.6% 154% -8,344 -57.2% 407.5% 35 0% 0%

Cash Flow Statement - Settlement

Finance Label 2016 2015 2014
Price Increase Price Increase Price Increase
cash flows from operating activities 6,253 7.8% 5,801 22.1% -61 0%
cash flows from investing activities -8,839 79.5% -4,925 144.8% -21,564 0%
cf from financing act. 0 0% -254 115% 21,409 0%
increases(decreases) in cash -2,586 516.4% 621 86% -216 0%
cash at the beginning of the period 5,924 15.9% 5,111 662.3% 518 0%
cash at the end of the period 3,495 41% 5,924 15.9% 302 0%
English